Diabetic retinopathy

https://doi.org/10.1016/S1098-3597(03)90015-9Get rights and content

Abstract

Diabetic retinopathy is the principal cause of irreversible blindness in patients of working age in the industrialized world (1,2). For some types of retinopathy (eg, proliferative disease), effective treatment in the form of laser photocoagulation has been available for more than 20 years, but many patients seek help too late when treatment is no longer effective. Macular edema, which is much more common in patients with type 2 diabetes mellitus, may be the presenting sign and therefore may already be established at diagnosis. If vision is significantly reduced, current treatment options are often ineffective. Screening of diabetic persons for early signs of retinopathy, which are treatable, improves the visual prognosis. Medical factors such as good blood glucose control, management of hypertension, and regulation of blood lipid levels are also considered to be of major importance.

References (30)

  • Photocoagulation for diabetic macular edema

    Arch Ophthalmol

    (1985)
  • J.C. Javitt et al.

    Cost-effectiveness of detecting and treating diabetic retinopathy

    Ann Intern Med

    (1996)
  • E.J. Dasbach et al.

    Cost effectiveness of strategies for detecting diabetic retinopathy

    Med Care

    (1991)
  • National Institute for Clinical Excellence

    Inherited clinical guideline E. Management of type 2 diabetes: Retinopathy-screening and early management

    (2002)
  • S.P. Harding et al.

    Sensitivity and specificity of photography and direct ophthalmoscopy in screening for sight-threatening eye disease-The Liverpool Diabetic Eye Study

    BMJ

    (1995)
  • Cited by (0)

    View full text